The physician fee schedule will be reduced by 2.93%, while other changes are in store for primary care, telehealth, and more.
The physician fee schedule will be reduced by 2.93%, while other changes are in store for primary care, telehealth, and more.
Written comments from stakeholders who use the fee schedule will be accepted until December 15th.
According to the DOJ, Medisca Inc. purchased resveratrol at $0.37 a gram, sold it for under $2.00 a gram, but reported an AWP of $777 per gram.
No deadline for feedback has been given, but the Commission will consider feedback for fee schedule changes for 2025.
Public comments for the proposed changes to the fee schedule will be accepted until October 23rd.
Drug payments increased eight-fold since 2018.
The meeting takes place October 16th to discuss the fee schedule and other matters.
Audits will focus on timely and accurate reimbursement, bill reporting, and delivery of benefits.
A November 5th meeting will review fee schedule revisions and certain reimbursement rules.
Requiring prior authorization would likely reduce utilization, and by extension reduce spend.
